Webmail
  • Home
  • About Us
    • Our Strategy
    • Our Governance
    • Highlighted Publications
    • Patents
  • Research & Development
    • Overview
    • Non-coding RNAs & Cancer
    • Cellular and Molecular Immunology
    • Translational Research
    • Epigenetics and Chromatin
    • Development of a New Drug for Cancer Therapy
    • Neuroimmunology
    • Immunoncology
    • Molecular Virology
    • Microbial Ecophysiology
    • Bioinformatics and Genome Biology
    • Computational Biology
    • Biology of Neurodegeneration
    • ASSOCIATED LABS
  • Advanced Training
    • Building Capacities
    • Ph.D. Programs
      • DOCTORATE IN IMMUNOLOGY AND MICROBIOLOGY
      • DOCTORATE IN BIOTECHNOLOGY AND BIOENTREPRENEURSHIP
      • DOCTORATE IN COMPUTATIONAL BIOLOGY
    • Constellation Program
    • International Exchange Program
    • Institutional Collaborations in Chile
  • Global Networks
    • International Alliances
    • Ciencia&Vida – California
      • Science & Friendship
      • Biotechnology Programs
    • Ciencia & Vida – Institut Curie
    • Encuentros
    • Other International Initiatives
  • Entrepreneurship
    • Science & Business Park
    • Andes Agriculture
    • Andes Biotechnologies
    • Ango
    • Connectomica
    • Eagle Genomics
    • Grupo Bios
    • Ingalfarma
    • Medzyme
    • Merken Biotech
    • Mikrovia
    • Meristem
    • Miroculus
    • MyoDynamis
    • Nova Mineralis
    • Phage Lab
    • Praxis Biotech
    • Thera Research
    • The Network Factory
    • Trancura Biosciences
  • Outreach
    • Eureka Program
    • Genetic Engineering Workshop for Opinion Leaders
    • Bus ConCiencia: Science-on-the-go
    • Editorial Ciencia & Vida
    • Ciencia Joven Academies
  • Cytometer Facilities

Currently browsing: “PERK”

The unfolded protein response during prostate cancer development

KEYWORDS: ATF6 • IRE1 • PERK • Prostate cancer • Sebastián Bernales • Tumorigenesis • Unfolded protein response (UPR)